Bosh sahifaEVGN • NASDAQ
add
Evogene Ltd
0,79 $
Seans yopilganidan keyin:(2,72%)+0,021
0,81 $
Yopilgan:5-mar, 18:00:01 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
0,84 $
Kunlik diapazon
0,73 $ - 0,84 $
Yillik diapazon
0,73 $ - 2,42 $
Bozor kapitalizatsiyasi
6,84 mln USD
Oʻrtacha hajm
835,28 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 312,00 ming | -82,63% |
Joriy xarajat | 2,88 mln | -64,76% |
Sof foyda | 3,87 mln | 150,77% |
Sof foyda marjasi | 1,24 ming | 392,27% |
Har bir ulushga tushum | -0,46 | 64,51% |
EBITDA | -2,44 mln | 64,22% |
Amaldagi soliq stavkasi | -0,04% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 15,96 mln | -20,02% |
Jami aktivlari | 26,09 mln | -34,97% |
Jami passivlari | 8,83 mln | -68,31% |
Umumiy kapital | 17,25 mln | — |
Tarqatilgan aksiyalar | 8,72 mln | — |
Narxi/balansdagi bahosi | 6,45 | — |
Aktivlardan daromad | -22,70% | — |
Kapitaldan daromad | -39,13% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 3,87 mln | 150,77% |
Operatsiyalardan naqd pul | -3,33 mln | 32,37% |
Sarmoyadan naqd pul | 10,91 mln | 441,12% |
Moliyadan naqd pul | -10,34 mln | -318,34% |
Naqd pulning sof oʻzgarishi | -2,70 mln | -247,46% |
Boʻsh pul | -385,62 ming | -131,18% |
Haqida
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Tashkil etilgan
1999
Sayt
Xodimlar soni
117